Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Other Non-Current Assets came in at $87.5 million in Q2 2026, up 83.07% on a YoY basis from $47.8 million in Q2 2025, and up 121.35% quarter-over-quarter from $39.5 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Other Non-Current Assets for 7 consecutive years, with $87.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 83.07% year-over-year to $87.5 million; the trailing twelve-month figure through Jun 2026 stood at $87.5 million (up 83.07% YoY), and the FY2025 full-year result was $45.2 million, up 2.26% from the prior year.
- Other Non-Current Assets advanced to $87.5 million in Q2 2026 per DNA's latest filing, from $39.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $97.9 million in Q2 2023 and bottomed at $39.5 million in Q1 2026.
- Historically, Other Non-Current Assets has averaged $62.4 million across 5 years, with a median of $55.5 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 120.87% in 2023, then tumbled 38.53% in 2024.
- Over 5 years, Other Non-Current Assets stood at $88.7 million in 2022, then tumbled by 34.57% to $58.1 million in 2023, then fell by 23.92% to $44.2 million in 2024, then advanced by 2.26% to $45.2 million in 2025, then surged by 93.67% to $87.5 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $87.5 million, $39.5 million, and $45.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 587.56 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 117.41 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 212,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 91,917.76 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.48 Mn |
| Mar 31, 2026 | 39.52 Mn |
| Dec 31, 2025 | 45.17 Mn |
| Sep 30, 2025 | 46.59 Mn |
| Jun 30, 2025 | 47.79 Mn |
| Mar 31, 2025 | 46.78 Mn |
| Dec 31, 2024 | 44.17 Mn |
| Sep 30, 2024 | 59.79 Mn |
| Jun 30, 2024 | 60.21 Mn |
| Mar 31, 2024 | 60.63 Mn |
| Dec 31, 2023 | 58.06 Mn |
| Sep 30, 2023 | 97.02 Mn |
| Jun 30, 2023 | 97.95 Mn |
| Mar 31, 2023 | 97.26 Mn |
| Dec 31, 2022 | 88.73 Mn |
| Sep 30, 2022 | 43.93 Mn |
| Jun 30, 2022 | 53.02 Mn |
| Mar 31, 2022 | 49.62 Mn |
| Dec 31, 2021 | 43.99 Mn |
| Sep 30, 2021 | 26.80 Mn |